A Covid-19 vaccine based on the messenger RNA technology of CureVac has yet to successfully emerge from clinical trials, lagging well behind the mRNA shot from rival BioNTech that has landed authorizations and approvals across the world. But CureVac is now trying to secure a win in another forum: the German courts. Tübingen, Germany-based CureVac contends that BioNTech’s vaccine […]
